Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

1.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

555
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.6K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Regulation of Heart Rates01:31

Regulation of Heart Rates

4.3K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
4.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

U.S. study of Scandinavian prison model expands.

Science (New York, N.Y.)·2025
Same author

Psychedelic trials face downsides of the 'trip'.

Science (New York, N.Y.)·2025
Same author

A new 'mini-CRISPR' flexes its editing power in monkey muscles.

Science (New York, N.Y.)·2025
Same author

Runners-up.

Science (New York, N.Y.)·2024
Same author

Storm warnings for FDA and CDC.

Science (New York, N.Y.)·2024
Same author

Preprint on Alzheimer's drug deaths ignites author dispute.

Science (New York, N.Y.)·2024

相关实验视频

Updated: Feb 24, 2026

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
06:56

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies

Published on: October 4, 2024

1.0K

呼吁停止心脏试验引发了令人不安的问题

Jennifer Couzin-Frankel

    Science (New York, N.Y.)
    |August 12, 2017
    PubMed
    概括

    No abstract available in PubMed .

    更多相关视频

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.9K
    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
    04:24

    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

    Published on: April 19, 2019

    12.7K

    相关实验视频

    Last Updated: Feb 24, 2026

    Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
    06:56

    Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies

    Published on: October 4, 2024

    1.0K
    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
    10:05

    Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

    Published on: July 7, 2016

    8.9K
    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
    04:24

    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

    Published on: April 19, 2019

    12.7K